🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Malaria is the most important human parasitic disease and is responsible of...
Status
Completed
Location
ISSR/Centre Muraz
Start Date
2010-06
Trial ID
NCT00852423
The main objective is to compare the safety and efficacy of 4 artemisinin-b...
Status
Completed
Location
Centre Muraz/IRSS
Start Date
2007-07
Trial ID
NCT00393679
Riamet® or Malarone® are both recommended as the first line treatment for u...
Status
Completed
Location
Hôpital Avicenne
Start Date
2010-07
Trial ID
NCT01150344
Treatments Being Tested
This is an open-label, adaptive study using the P. falciparum induced blood...
Status
Completed
Location
South Bank
Start Date
2023-08-01
Trial ID
NCT05979207
The aim of such a study is to evaluate the impact of a therapeutic dose of ...
Status
Completed
Location
SGS aster s.a.s
Start Date
2010-02
Trial ID
NCT01103830
This is a single-centre, open-label, Phase Ib study designed to assess if i...
Status
Completed
Location
SGS Belgium NV Clinical Pharmacology Unit
Start Date
2020-02-19
Trial ID
NCT04310085
Treatments Being Tested
In the Democratic Republic of Congo (DRC), malaria is an important cause of...
Status
Completed
Location
General reference hospital of Chamfubu
Start Date
2008-04
Trial ID
NCT01567423
Treatments Being Tested
This is a two-arm study aiming at recruiting 150 patients to assess the eff...
Status
Completed
Location
Clinical Reaserch Unit
Start Date
2012-10
Trial ID
NCT01697787
Treatments Being Tested
This study will assess the safety and efficacy of artemether-lumefantrine t...
Status
Completed
Location
Kemri-Wellcome Trust Programme
Start Date
2002-07
Trial ID
NCT00709969
Treatments Being Tested
The purpose of this study is to assess the antimalarial activity, pharmacok...
Status
Completed
Location
USC Clinical Trials Brisbane (South Bank) ( Site 0001)
Start Date
2024-04-18
Trial ID
NCT06294912
Treatments Being Tested